← Leaderboards
Michael J Yaszemski
Mayo Clinic Coll Of Medicine, Rochester
$10,057,008
Attributed
$16,270,231
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–22$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$16,270,231 · 8
By mechanism
R01$13,062,505 · 5
R44$2,981,726 · 1
R34$211,000 · 1
R13$15,000 · 1
Top collaborators
- Lichun Lu20 shared
- Ara Nazarian2 shared
- Ashkan Vaziri2 shared
- Antonios G. Mikos1 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseVertebral ColumnDesignDefectMechanicsPolymersInjectableBiocompatible MaterialsBone RegenerationOperative Surgical ProceduresReconstructionSpinalCrosslinkShapesPre-ClinicalScaffoldIn VivoMinimally InvasivePropertyHydrogelsCaprolactonePoly(Propylene Fumarate)BonePrograms
Grant awards (41)
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$523,072
R01 · FY2022 · AR
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$472,356
R01 · FY2021 · AR
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$67,282
R01 · FY2021 · AR
CTRA Software Solution for Fracture Risk Assessment of Axial Skeleton$1,490,863
R44 · FY2020 · AG
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$527,228
R01 · FY2020 · AR
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$50,463
R01 · FY2020 · AR
CTRA Software Solution for Fracture Risk Assessment of Axial Skeleton$1,490,863
R44 · FY2019 · AG
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$430,335
R01 · FY2019 · AR
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$385,101
R01 · FY2019 · AR
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$437,629
R01 · FY2018 · AR
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$457,653
R01 · FY2017 · AR
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$442,262
R01 · FY2016 · AR
AAOS/ORS Translating Orthopaedic Technologies into Clinical Practice: Pathways from Novel Idea to Improvements in Standard of Care Research Symposium$15,000
R13 · FY2016 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$469,251
R01 · FY2015 · AR
Mayo Clinic Rice University Dental, Oral and Craniofacial Tissue Regeneration Consortium Resource Center$211,000
R34 · FY2015 · DE · contact PI
Injectable and Preformed Osteoinductive Biodegradable Composites$459,871
R01 · FY2014 · EB · contact PI
Injectable and Preformed Osteoinductive Biodegradable Composites$393,715
R01 · FY2013 · EB · contact PI
Injectable and Preformed Osteoinductive Biodegradable Composites$576,897
R01 · FY2012 · EB · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$469,223
R01 · FY2012 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$424,526
R01 · FY2011 · AR · contact PI
Injectable and Preformed Osteoinductive Biodegradable Composites$337,480
R01 · FY2011 · EB · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$414,949
R01 · FY2010 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$476,926
R01 · FY2009 · AR · contact PI
Osteoinductive Injectable Degradable Polymeric Scaffold$449,645
R01 · FY2008 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$423,592
R01 · FY2008 · AR · contact PI
Osteoinductive Injectable Degradable Polymeric Scaffold$43,957
R01 · FY2008 · AR · contact PI
Osteoinductive Injectable Degradable Polymeric Scaffold$384,157
R01 · FY2007 · AR · contact PI
Injectable Osteoinductive Biodegradable Composites$311,478
R01 · FY2007 · EB · contact PI
Genomic Assessment of Clinical Variability in OGS$516,382
R01 · FY2006 · AR · contact PI
Osteoinductive Injectable Degradable Polymeric Scaffold$383,158
R01 · FY2006 · AR · contact PI
Injectable Osteoinductive Biodegradable Composites$320,781
R01 · FY2006 · EB · contact PI
Osteoinductive Injectable Degradable Polymeric Scaffold$350,448
R01 · FY2005 · AR
Injectable Osteoinductive Biodegradable Composites$328,500
R01 · FY2005 · EB
Osteoinductive Injectable Degradable Polymeric Scaffold$53,005
R01 · FY2005 · AR
Injectable Osteoinductive Biodegradable Composites$328,500
R01 · FY2004 · EB
Osteoinductive Injectable Degradable Polymeric Scaffold$318,683
R01 · FY2004 · AR
Injectable Osteoinductive Biodegradable Composites$328,500
R01 · FY2003 · EB
OSTEOINDUCTIVE INJECTABLE DEGRADEABLE POLYMERIC SCAFFOLD$176,375
R01 · FY2003 · AR
OSTEOINDUCTIVE INJECTABLE DEGRADEABLE POLYMERIC SCAFFOLD$176,375
R01 · FY2002 · AR
OSTEOINDUCTIVE INJECTABLE DEGRADEABLE POLYMERIC SCAFFOLD$176,375
R01 · FY2001 · AR
OSTEOINDUCTIVE INJECTABLE DEGRADEABLE POLYMERIC SCAFFOLD$176,375
R01 · FY2000 · AR